• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

囊性纤维化患儿使用的干粉吸入器的必备条件。

Prerequisites for a dry powder inhaler for children with cystic fibrosis.

作者信息

Lexmond Anne J, Hagedoorn Paul, Frijlink Henderik W, Rottier Bart L, de Boer Anne H

机构信息

Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Groningen, The Netherlands.

Division of Pediatric Pulmonology and Pediatric Allergology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

PLoS One. 2017 Aug 11;12(8):e0183130. doi: 10.1371/journal.pone.0183130. eCollection 2017.

DOI:10.1371/journal.pone.0183130
PMID:28800360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5553717/
Abstract

Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient's inhalation manoeuvre. Children are an especially challenging target population for DPI development due to the large variability in understanding and inspiratory capacities. We previously performed a study in which we determined the prerequisites for a paediatric DPI in a mostly healthy paediatric population, for which we used an empty test inhaler with variable internal airflow resistance and mouthpiece. In the current study we investigated what specifications are required for a DPI for children with cystic fibrosis (CF), for which we expanded on our previous findings. We recorded flow profiles of 35 children with CF (aged 4.7-14.7 years) at three airflow resistances (0.031-0.045 kPa0.5.min.L-1) from which various inspiratory parameters were computed. Obstructions in the mouth during inhalation were recorded with a sinuscope. All children were able to perform a correct inhalation manoeuvre, although video analysis showed that children did not place the inhaler correctly in the mouth in 17% of the cases. No effect was found of medium to high airflow resistance on total inhaled volume, which implies that the whole resistance range tested is suitable for children with CF aged 4-14 years. No effect could be established of either mouthpiece design or airflow resistance on the occurrence of obstructions in the mouth cavity. This study confirms our previous conclusion that the development of DPIs specifically for children is highly desired. Such a paediatric DPI should function well at 0.5 L inhaled volume and a peak inspiratory flow rate of 20 to 30 L/min, depending on the internal airflow resistance. This resistance can be increased up to 0.045 kPa0.5.min.L-1 (medium-high) to reduce oropharyngeal deposition. A higher resistance may be less favourable due to its compromising effect on PIF and thereby on the energy available for powder dispersion.

摘要

正确的吸入技术对于有效使用干粉吸入器(DPI)至关重要,因为其有效性很大程度上取决于患者的吸入动作。由于理解能力和吸气能力差异很大,儿童是DPI开发中特别具有挑战性的目标人群。我们之前进行了一项研究,在主要为健康儿童的人群中确定了儿科DPI的先决条件,为此我们使用了具有可变内部气流阻力和吸嘴的空测试吸入器。在当前研究中,我们调查了囊性纤维化(CF)儿童使用的DPI需要哪些规格,为此我们扩展了之前的研究结果。我们记录了35名CF儿童(年龄4.7 - 14.7岁)在三种气流阻力(0.031 - 0.045 kPa0.5.min.L-1)下的流量曲线,并据此计算了各种吸气参数。使用鼻窦镜记录吸入过程中口腔内的阻塞情况。所有儿童都能够进行正确的吸入动作,尽管视频分析显示17%的情况下儿童未将吸入器正确放入口中。未发现中到高气流阻力对总吸入量有影响,这意味着所测试的整个阻力范围适用于4 - 14岁的CF儿童。未发现吸嘴设计或气流阻力对口腔内阻塞的发生有影响。本研究证实了我们之前的结论,即非常需要专门为儿童开发的DPI。这种儿科DPI应在吸入量为0.5 L且吸气峰值流速为20至30 L/min时良好运行,具体取决于内部气流阻力。该阻力可增加至0.045 kPa0.5.min.L-1(中高)以减少口咽部沉积。由于其对吸气峰值流速(PIF)以及进而对粉末分散可用能量的不利影响,更高的阻力可能不太有利。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b901/5553717/aff81c220f2e/pone.0183130.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b901/5553717/cf121af9205f/pone.0183130.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b901/5553717/aff81c220f2e/pone.0183130.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b901/5553717/cf121af9205f/pone.0183130.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b901/5553717/aff81c220f2e/pone.0183130.g002.jpg

相似文献

1
Prerequisites for a dry powder inhaler for children with cystic fibrosis.囊性纤维化患儿使用的干粉吸入器的必备条件。
PLoS One. 2017 Aug 11;12(8):e0183130. doi: 10.1371/journal.pone.0183130. eCollection 2017.
2
Effect of inhaler design variables on paediatric use of dry powder inhalers.吸入器设计变量对儿科使用干粉吸入器的影响。
PLoS One. 2014 Jun 5;9(6):e99304. doi: 10.1371/journal.pone.0099304. eCollection 2014.
3
Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.干粉吸入器阻力对6岁及以上囊性纤维化患者吸气流量和容积的影响。
J Aerosol Med. 2006 Winter;19(4):456-65. doi: 10.1089/jam.2006.19.456.
4
[Peak inspiratory flow generated through different analogue dry powder inhalers in Shenzhen healthy preschool children].[深圳健康学龄前儿童使用不同模拟干粉吸入器产生的吸气峰流速]
Zhonghua Er Ke Za Zhi. 2008 Feb;46(2):98-103.
5
Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis.吸入用环丙沙星干粉:非囊性纤维化支气管扩张症患者的吸气流量。
J Aerosol Med Pulm Drug Deliv. 2019 Jun;32(3):156-163. doi: 10.1089/jamp.2018.1464. Epub 2019 Mar 8.
6
The inhalation characteristics of patients when they use different dry powder inhalers.患者使用不同干粉吸入器时的吸入特性。
J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):35-42. doi: 10.1089/jamp.2013.1119. Epub 2014 May 9.
7
Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA® Dry Powder Inhaler.哮喘和慢性阻塞性肺疾病的疾病严重程度对通过ELLIPTA®干粉吸入器的特定吸入器吸入特征的影响。
J Aerosol Med Pulm Drug Deliv. 2015 Dec;28(6):486-97. doi: 10.1089/jamp.2015.1224. Epub 2015 Sep 15.
8
Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.使用内置刻度盘装置测量哮喘儿童吸入峰值流速,以模拟低阻力(都保)和高阻力(准纳器)干粉吸入器。
Pediatr Pulmonol. 2005 May;39(5):447-51. doi: 10.1002/ppul.20180.
9
Inhalation Profiles Through a Dry Powder Inhaler: Relation Between Inhalation Technique and Spirometric Measures.通过干粉吸入器的吸入特征:吸入技术与肺量计测量之间的关系。
J Aerosol Med Pulm Drug Deliv. 2021 Dec;34(6):346-357. doi: 10.1089/jamp.2020.1663. Epub 2021 Apr 20.
10
Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.正压干粉吸入器在儿童中的应用进展:使用垂直雾化室和三维棒状阵列接口。
Pharm Res. 2020 Aug 30;37(9):177. doi: 10.1007/s11095-020-02889-7.

引用本文的文献

1
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis.吸入用妥布霉素干粉在囊性纤维化儿童中的耐受性和药代动力学评估。
Pharmaceutics. 2025 Mar 7;17(3):347. doi: 10.3390/pharmaceutics17030347.
2
Characterization of Pediatric Extrathoracic Aerosol Deposition with Air-Jet Dry Powder Inhalers.使用空气喷射干粉吸入器对小儿胸外气溶胶沉积的特征描述
J Aerosol Sci. 2025 Jan;183. doi: 10.1016/j.jaerosci.2024.106474. Epub 2024 Sep 28.
3
Climate Policy and Pediatric Asthma: How Transition to Nonhydrofluorocarbon Propellants Will Disproportionately Impact Children.

本文引用的文献

1
Inhalation of tobramycin using simulated cystic fibrosis patient profiles.使用模拟囊性纤维化患者概况吸入妥布霉素。
Pediatr Pulmonol. 2016 Nov;51(11):1159-1167. doi: 10.1002/ppul.23451. Epub 2016 May 1.
2
Can 'extrafine' dry powder aerosols improve lung deposition?“超细微”干粉气雾剂能否改善肺部沉积?
Eur J Pharm Biopharm. 2015 Oct;96:143-51. doi: 10.1016/j.ejpb.2015.07.016. Epub 2015 Jul 26.
3
The clinical relevance of dry powder inhaler performance for drug delivery.干粉吸入器用于药物递送的性能的临床相关性。
气候政策与儿童哮喘:向非氢氟烃推进剂的转变将如何对儿童产生不成比例的影响。
Ann Am Thorac Soc. 2024 Sep;21(9):1242-1244. doi: 10.1513/AnnalsATS.202401-115VP.
4
Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI.使用喷雾干燥抗生素制剂和儿科空气射流干粉吸入器,近乎消除儿童体外预测的胸腔外气溶胶沉积。
Pharm Res. 2023 May;40(5):1193-1207. doi: 10.1007/s11095-022-03316-9. Epub 2022 Jun 27.
5
High-Efficiency Dry Powder Aerosol Delivery to Children: Review and Application of New Technologies.向儿童高效递送干粉气雾剂:新技术综述与应用
J Aerosol Sci. 2021 Mar;153. doi: 10.1016/j.jaerosci.2020.105692. Epub 2020 Oct 14.
6
Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.干粉吸入器患者接口的开发,以改善儿童的气溶胶输送。
AAPS PharmSciTech. 2020 May 25;21(5):157. doi: 10.1208/s12249-020-01667-3.
7
Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.开发一种用于儿童口服或经鼻气溶胶给药的在线干粉吸入器。
J Aerosol Med Pulm Drug Deliv. 2020 Apr;33(2):83-98. doi: 10.1089/jamp.2019.1540. Epub 2019 Aug 29.
Respir Med. 2014 Aug;108(8):1195-203. doi: 10.1016/j.rmed.2014.05.009. Epub 2014 May 24.
4
Effect of inhaler design variables on paediatric use of dry powder inhalers.吸入器设计变量对儿科使用干粉吸入器的影响。
PLoS One. 2014 Jun 5;9(6):e99304. doi: 10.1371/journal.pone.0099304. eCollection 2014.
5
Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways.比较 MDI 和 DPI 气溶胶沉积的体外实验和新的传导气道随机个体路径(SIP)模型。
Pharm Res. 2012 Jun;29(6):1670-88. doi: 10.1007/s11095-012-0691-y.
6
What the pulmonary specialist should know about the new inhalation therapies.肺部专家应该了解的新型吸入疗法。
Eur Respir J. 2011 Jun;37(6):1308-31. doi: 10.1183/09031936.00166410. Epub 2011 Feb 10.
7
The ADMIT series--issues in inhalation therapy. 5) Inhaler selection in children with asthma.《ADMIT系列——吸入疗法问题。5)哮喘患儿的吸入器选择》
Prim Care Respir J. 2010 Sep;19(3):209-16. doi: 10.4104/pcrj.2010.00043.
8
Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD.干粉吸入器使用不当对哮喘和慢性阻塞性肺疾病患者管理的影响。
Respir Med. 2008 Apr;102(4):593-604. doi: 10.1016/j.rmed.2007.11.003. Epub 2007 Dec 20.
9
Effect of dry powder inhaler resistance on the inspiratory flow rates and volumes of cystic fibrosis patients of six years and older.干粉吸入器阻力对6岁及以上囊性纤维化患者吸气流量和容积的影响。
J Aerosol Med. 2006 Winter;19(4):456-65. doi: 10.1089/jam.2006.19.456.
10
Airway function in infants newly diagnosed with cystic fibrosis.新诊断为囊性纤维化的婴儿的气道功能
Lancet. 2001 Dec 8;358(9297):1964-5. doi: 10.1016/s0140-6736(01)06970-7.